Qiagen reports over 1,000 placements of EZ2 Connect instrument

Qiagen (QGEN) announced it has reached a significant milestone with over 1,000 placements of the EZ2 Connect automated sample preparation instrument, an advancement of the EZ1 instrument line. Launched in 2021, the updated EZ2 Connect has quickly become a market-leading instrument for sample preparation and data management, contributing to a total of more than 5,500 EZ series instruments placed globally. EZ2 Connect is designed to automate the entire process of nucleic acid purification, reducing hands-on time and increasing throughput while maintaining high precision and reproducibility. Using EZ2 Connect enables researchers to focus more on data analysis and interpretation rather than repetitive manual sample processing. The system is particularly beneficial for laboratories handling medium volumes of samples for use across a range of downstream molecular biology research applications, such as digital PCR and next-generation sequencing. “Achieving over 1,000 placements of the EZ2 Connect highlights the trust our customers place in QIAGEN’s automation portfolio to drive their laboratory operations,” said Nitin Sood, Senior Vice President, Head of the Life Sciences Business Area at QIAGEN. “We are committed to providing advanced automation that reduces manual tasks and gives researchers more time for analyses. With a comprehensive consumables portfolio, we are supporting researchers in various application areas.”